Natco Pharma Limited has informed the Exchange regarding a press release dated February 04, 2023, titled "USFDA COMPLETES INSPECTION OF NATCO s VIZAG FORMULATION FACILITY".
Natco Pharma Limited has informed the Exchange regarding a press release dated February 04, 2023, titled "USFDA COMPLETES INSPECTION OF NATCO s VIZAG FORMULATION FACILITY".